Dark
Streaming/Mobile
Old Site
Home
Daily
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:15:03 EDT Tue 28 Mar 2023
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
News for U:TCBP from 2022-03-29 to 2023-03-28 - 32 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2023-03-28 08:05
U
U:TCBP
News Release
200
TC BioPharm Announces Pricing of $5.5 Million Public Offering
2023-03-22 08:30
U
U:TCBP
News Release
200
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead
2023-03-16 12:00
U
U:TCBP
News Release
200
TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2)
2023-03-07 08:30
U
U:TCBP
News Release
200
TC BioPharm Shifts Focus to FDA Clinical Trials
2023-02-23 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer
2023-02-21 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies
2023-02-14 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces New Chair of the Board, Arlene Morris
2023-02-13 16:15
U
U:TCBP
News Release
200
TC BioPharm to Reschedule Shareholder Update Call and Webcast
2023-02-07 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety Cohort
2023-01-30 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
2023-01-20 08:30
U
U:TCBP
News Release
200
TC BioPharm to Host Shareholder Update Call
2023-01-19 08:30
U
U:TCBP
News Release
200
TC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)
2023-01-17 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
2022-12-12 09:00
U
U:TCBP
News Release
200
TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update
2022-11-30 18:43
U
U:TCBP
News Release
200
TC BioPharm Announces Closing of $7.35 Million Private Placement
2022-11-28 08:00
U
U:TCBP
News Release
200
TC BioPharm Announces $7.35 Million Private Placement
2022-11-22 08:00
U
U:TCBP
News Release
200
TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune ‚ ®, in Patients with Acute Myeloid Leukemia
2022-10-26 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise
2022-10-03 08:30
U
U:TCBP
News Release
200
TC BioPharm to Present at Upcoming Investor Conferences
2022-09-13 09:30
U
U:TCBP
News Release
200
TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune(TM)
2022-08-22 08:30
U
U:TCBP
News Release
200
TC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference
2022-07-25 08:30
U
U:TCBP
News Release
200
TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit
2022-07-08 08:30
U
U:TCBP
News Release
200
TC BioPharm CEO, Bryan Kobel to Speak at the "Innovating Cell and Gene Therapy Quality Control Conference 2022"
2022-06-07 16:00
U
U:TCBP
News Release
200
TC Biopharm Announces Closing of $4 Million Underwritten Public Offering
2022-06-02 18:10
U
U:TCBP
News Release
200
TC BioPharm Announces Pricing of $4 Million Underwritten Public Offering
2022-05-31 10:00
U
U:TCBP
News Release
200
TC BioPharm Highlights Need for Disruptive Treatment as Acute Myeloid Leukemia Cases Rise Globally
2022-05-23 08:30
U
U:TCBP
News Release
200
Kuick Research Recognizes TC BioPharm as a Key Player in the Gamma-Delta T Cell Therapy Market
2022-05-18 08:30
U
U:TCBP
News Release
200
TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts
2022-05-03 08:30
U
U:TCBP
News Release
200
TC BioPharm Invited to Present at LD Micro Conference
2022-04-26 08:45
U
U:TCBP
News Release
200
TC BioPharm to Participate in Upcoming Conferences
2022-04-21 08:00
U
U:TCBP
News Release
200
TC BioPharm Donates to Leukemia and Lymphoma Society in Sponsorship of World AML Day
2022-04-06 08:30
U
U:TCBP
News Release
200
TC BioPharm Receives CryoTC(TM) Trademark for Proprietary Cell Freezing Process